Pei Feng, Zhu Yi. Clinical Significance of Cytokeratin18 Fragments in Diagnosis of Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(04): 439-441. DOI: 10.3971/j.issn.1000-8578.2012.04.018
Citation:
Pei Feng, Zhu Yi. Clinical Significance of Cytokeratin18 Fragments in Diagnosis of Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(04): 439-441. DOI: 10.3971/j.issn.1000-8578.2012.04.018
Pei Feng, Zhu Yi. Clinical Significance of Cytokeratin18 Fragments in Diagnosis of Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(04): 439-441. DOI: 10.3971/j.issn.1000-8578.2012.04.018
Citation:
Pei Feng, Zhu Yi. Clinical Significance of Cytokeratin18 Fragments in Diagnosis of Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(04): 439-441. DOI: 10.3971/j.issn.1000-8578.2012.04.018
Objective To explore clinical significance of Cytokeratin18 Fragments in diagnosis of gastric cancer. Methods CLIA(chemiluminescence immunology analysis) was used to detect the serum level of CK18-3A9 in 236 cases of gastric cancer(186 cases of Gastric adenocarcinoma,50 cases of Signet-ring cell carcinoma),150 cases of gastritis and gastric ulcer,and 165 healthy persons.ECLIA (electro-chemiluminescence analysis) was used to detect the serum levels of markers(CEA,CA199,CA72-4) in those people. Results The sensitivity and specificity of CK18-3A9 to diagnose gastric cancer were 36.02% and 97.5% respectively.The sensitivity and specificity of combined markers(CEA+CA199+CA72-4) were 33.47% and 97.5% respectively.The combined detection of CK18-3A9 and markers(CEA+CA199+CA72-4) to diagnose gastric cancer could increase the sensitivity up to 55.08% with significant difference (P<0.05),also with the same specificity. Conclusion The detection of serum CK18-3A9 is helpful in the diagnosis of gastric cancer.Combination of serum CK18-3A9 with other markers(CEA+CA199+CA72-4) would improve the accuracy in diagnosis of gastric cancer.
Barak V,Goike H,Panaretakis KW,et al.Clinical utility of cytokeratins as tumor markers[J].Clin Biochem,2004,37(7):529-540.
[2]
Linder S,Havelka AM,Ueno T,et al.Determining tumor apoptosis and necrosis in patient serumusing cytokeratin 18 as a biomarker[J].Cancer Lett,2004,214(1):1-9.
[3]
Yao KY,Tian R.Clinical significance of joint detection of CEA and CA199 in Midlate gastrointestinal tract cancer[J].Zhong Liu Fang Zhi Yan Jiu,1997,27(6):387.[姚奎元,田韧.血清CEA、CA199联合检测中、晚期消化道癌肿[J].肿瘤防治研究,1997,27(6):387.]
[4]
Xu W,Zhang MW,Huang J,et al.Diagnosis of micrometastasis in lymph nodes of patients withgastric cancer by using CK18 mRNA RG-PCR[J].Ji Lin Da Xue Xue Bao(Medical Science),2004,30(1):111-113.[续薇,张明威,黄晶,等.细胞角蛋白18基因诊断胃癌淋巴结微转移[J].吉林大学学报(医学版),2004,30(1):111-113.]